Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2008143

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2008143

Brucellosis Vaccines Market, By Type, By Application, By Geography

PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Brucellosis Vaccines Market is estimated to be valued at USD 1.2 Bn in 2026 and is expected to reach USD 2.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1.2 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.30% 2033 Value Projection: USD 2.4 Bn

Brucellosis is an infectious disease caused by bacteria. Animals that are most commonly infected include sheep, cattle, goats, pigs, and dogs, among others. These disease can also occur in humans when they are in contact with infected animals or animal products contaminated with bacteria.

Moreover, RB51 Vaccine, S19 Vaccine, B19 Vaccine and Others (45/20 vaccine, SR82 vaccine, etc.) are the type of vaccine used for the brucellosis in animals.

Furthermore, increasing launches of brucellosis vaccination programmes is expected to drive the market growth over the forecast period.

In August 2021, brucella vaccination program was launched at Thoubal, Manipur, India for the control and eradication of brucellosis in female calves of 4-8 months age group.

Market Dynamics

Increasing prevalence of brucellosis is expected to drive the global brucellosis vaccines market growth over the forecast period. For instance, according to an article published by the National Center for Biotechnology Information, a series of databases relevant to biotechnology and biomedicine, brucellosis is the world's most widespread zoonotic disease, a type of disease that passes from an animal to a human. The source stated that there are a reported 500,000 cases of human brucellosis each year, globally. However, true incidence is estimated to be 5,000,000 to 12,500,000 cases each year, globally.

According to the same source, brucellosis is recognized as the world's most common laboratory-acquired infection.

Key features of the study

  • This report provides an in-depth analysis of the global brucellosis vaccines market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global brucellosis vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Merck & Co., Inc., CZ Vaccines, Colorado Serum Company, Indian Immunologicals Ltd., Hester Biosciences Limited, Veterinary Technologies Corporation, Jordan Bio-industries Center, Laboratorios Tornel, Fivet Animal Health and VETAL Animal Health Products Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global brucellosis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global brucellosis vaccines market

Market Segmentation

  • By Type
    • RB51 Vaccine
    • S19 Vaccine
    • B19 Vaccine
    • Others (45/20 vaccine, SR82 vaccine, etc.)
  • By Application
    • Cattle
    • Sheep
    • Goat
    • Others (swine, horses, etc.)
  • By Regional Insights
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Merck & Co., Inc.
    • CZ Vaccines
    • Colorado Serum Company
    • Indian Immunologicals Ltd.
    • Hester Biosciences Limited
    • Veterinary Technologies Corporation
    • Jordan Bio-industries Center
    • Laboratorios Tornel
    • Fivet Animal Health
    • VETAL Animal Health Products Inc.
Product Code: CMI5038

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Launch
  • Regulatory Guidelines
  • Acquisitions, Collaborations, & Partnerships
  • Epidemiology
  • PEST Analysis

4. Global Brucellosis Vaccines Market, By Type, 2026 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021-2033
    • Segment Trends
  • RB51 Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • S19 Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • B19 Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others (45/20 vaccine, SR82 vaccine, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Brucellosis Vaccines Market, By Application, 2026 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021-2033
    • Segment Trends
  • Cattle
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Sheep
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Goat
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others (swine, horses, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Brucellosis Vaccines Market, By Region, 2026 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2033
  • North America
    • Market Size and Forecast, By Type, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021-2033, (USD Bn)
    • Market Size and Forecast, By Region/Country, 2021-2033, (USD Bn)
  • South Africa
  • Central Africa
  • North Africa

7. Competitive Landscape

  • Competitive Snapshot
  • Merck & Co., Inc.
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • CZ Vaccines
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Colorado Serum Company
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Indian Immunologicals Ltd.
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Hester Biosciences Limited
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Veterinary Technologies Corporation
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Jordan Bio-industries Center
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Laboratorios Tornel
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Fivet Animal Health
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • VETAL Animal Health Products Inc.
    • Company Overview
    • Application Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!